NCT03231735

Brief Summary

The purpose of this study is to determine, in preterm infants less than 37 weeks gestation with respiratory distress who are ventilated in the first 48 hours after birth, if mid frequency ventilation strategy using ventilator rate of ≥ 60 to ≤ 150 per minute compared with standard frequency ventilation strategy using ventilator rates of ≥ 20 to \< 60 per minute will increase the number of alive ventilator-free days after randomization and reduce the risk of ventilator induced lung injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2017

Longer than P75 for phase_2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 27, 2017

Completed
6 days until next milestone

Study Start

First participant enrolled

August 2, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2021

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

4.3 years

First QC Date

July 25, 2017

Last Update Submit

October 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Alive ventilator free days

    The number of days alive and ventilator-free

    Days 1-28 after birth

Secondary Outcomes (17)

  • Alive at day 28 after birth

    Day 28 after birth

  • Ventilator free

    Day 28 after birth

  • Bronchopulmonary dysplasia

    Measured at 36 weeks' postmenstrual age

  • Bronchopulmonary dysplasia

    Measured at 36 weeks' postmenstrual age

  • Air leak syndrome

    Day 1-28 after birth

  • +12 more secondary outcomes

Study Arms (2)

Mid frequency ventilation

OTHER

Mid frequency ventilation delivered at rates \> 60 per minute and ≤ 150 per minute, with patient triggered ventilation and pressure support.

Device: Mid frequency ventilation

Standard frequency ventilation

OTHER

Standard frequency ventilation delivered at rates \< 60 per minute and ≥ 20 per minute, with patient triggered ventilation and pressure support.

Device: Standard frequency ventilation

Interventions

Mechanical ventilator used at rates \> 60 per minute and ≤ 150 per minute, with patient triggered ventilation and pressure support.

Mid frequency ventilation

Mechanical ventilator used at rates \< 60 per minute and ≥ 20 per minute, with patient triggered ventilation and pressure support.

Standard frequency ventilation

Eligibility Criteria

Age1 Day - 3 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants ≥ 23+0/7 weeks and ≤ 36+6/7 who are intubated and mechanically ventilated for respiratory distress syndrome (defined by use of surfactant) within 48 hours after birth
  • Infants whose parents/legal guardians have provided consent for enrollment
  • Inborn or outborn infants transferred to this center before 48 hours after birth
  • Ventilator rate ≤ 80 per minute prior to enrollment

You may not qualify if:

  • a major malformation, a neuromuscular condition that affects respiration, or terminal illness or decision to withhold or limit support.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Alabama at Birmingham

Birmingham, Alabama, 35249, United States

Location

University of South Alabama

Mobile, Alabama, 36604, United States

Location

MeSH Terms

Conditions

Ventilator-Induced Lung InjuryRespiratory Distress SyndromeBronchopulmonary DysplasiaPremature Birth

Condition Hierarchy (Ancestors)

Lung InjuryLung DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Waldemar A Carlo, MD

    University of Alabama at Birmingham

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a randomized controlled trial with a 1:1 parallel allocation of infants to mid or standard frequency ventilation using stratified permuted block design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 25, 2017

First Posted

July 27, 2017

Study Start

August 2, 2017

Primary Completion

November 21, 2021

Study Completion

October 10, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations